TYMORA ANALYTICAL OPERATIONS LLC
West Lafayette, IN · Medtech · Private
Companion diagnostic panel predicting dasatinib sensitivity in T-ALL leukemia patients via LCK activation biomarkers
- Grants
- $9.4M
- 22 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 7
- 1 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Multiplexed detection and imaging of protein phosphorylation based on soluble nanopolymers | $897,133 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Multiplexed detection and imaging of protein phosphorylation based on soluble nanopolymers | $451,538 | |
| Federal grant | Department of Health and Human Services · Phase I · Metal ion-functionalized soluble nanopolymers: A new analytical platform for plas | $328,449 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing gel-based platform for quantitative phosphoproteomics | $150,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Multiplexed detection and imaging of protein phosphorylation based on soluble nanopolymers | $445,595 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing novel RPPA for the detection of metastatic prostate cancer | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing novel RPPA for the detection of metastatic prostate cancer | $227,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing novel RPPA for the detection of metastatic prostate cancer | $2,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of non-invasive research and diagnostics platform for Alzheimer's disease based on plasma exosomes | $215,369 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of non-invasive research and diagnostics platform for Alzheimer's disease based on plasma exosomes | $215,369 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of non-invasive biomarker discovery and diagnostics approach for bladder cancer based on urine proteome and phosphoproteome | $224,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing EV surface proteins as biosignatures for Alzheimer's disease (AD) | $244,909 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing EV surface proteins as biosignatures for Alzheimer's disease (AD) | $244,909 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing high throughput measurement of thiopurine in DNA by mass spectrometry | $299,975 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of non-invasive biomarker discovery and diagnostics approach for bladder cancer based on urine proteome and phosphoproteome | $1,300,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of non-invasive biomarker discovery and diagnostics approach for bladder cancer based on urine proteome and phosphoproteome | $600,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Development of companion diagnostics for dasatinib-based personalized therapy for T-ALL | $310,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Development of companion diagnostics for dasatinib-based personalized therapy for T-ALL | $310,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of non-invasive biomarker discovery and diagnostics approach for bladder cancer based on urine proteome and phosphoproteome | $700,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of lavage EV protein biomarkers for minimally-invasive detection of endometrial cancer | $290,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Validation and clinicaldevelopment of plasma EV protein biomarkers for minimally-invasive detection of Alzheimersdisease | $815,028 | |
| Federal grant | Department of Health and Human Services · Phase II · Validation and clinicaldevelopment of plasma EV protein biomarkers for minimally-invasive detection of Alzheimersdisease | $854,102 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1782 | LEVATE LLC | — | — |
| 1783 | Arnoldware Applications LLC | — | — |
| 1784 | SynderBio Inc. | — | — |
| 1785 | TYMORA ANALYTICAL OPERATIONS LLC | — | — |
| 1786 | COLDSTEEL LASER, INC | — | — |
| 1787 | LA JOLLA ALCOHOL RESEARCH INC | — | — |
| 1788 | Cambre Kelly | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods For Affinity-based Non-antibody Capture And Purification Of Extracellular Vesiclesapplication
- Extracellular Vesicle Biomarkers For Bladder Cancerapplication
- Extracellular Vesicle Biomarkers For Endometrial Cancerapplication
- Methods For Affinity-based Non-antibody Capture And Purification Of Extracellular Vesiclesgranted
- Extracellular Vesicle Biomarkers For Pancreatic Cancer Detection, Diagnosis And Monitoringapplication
- Chemically functionalized array to analyze protein modificationsapplication
- Methods To Isolate, Extract, Identify And Detect Phosphoproteins In Biofluids For Biomarker Discovery And Disease Diagnosisapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.